Vo, T. A., Abedi, S., Schneider, K., Chwa, M., & Kenney, M. C. (2018). Effects of bevacizumab, ranibizumab, and aflibercept on phagocytic properties in human RPE cybrids with AMD versus normal mitochondria. Exp Eye Res.
Chicago Stili AlıntıVo, Thomas A., Sina Abedi, Kevin Schneider, Marilyn Chwa, ve M. Cristina Kenney. "Effects of Bevacizumab, Ranibizumab, and Aflibercept On Phagocytic Properties in Human RPE Cybrids With AMD Versus Normal Mitochondria." Exp Eye Res 2018.
MLA AlıntıVo, Thomas A., et al. "Effects of Bevacizumab, Ranibizumab, and Aflibercept On Phagocytic Properties in Human RPE Cybrids With AMD Versus Normal Mitochondria." Exp Eye Res 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..